Company Analysis

Rockwell Medical, Inc. (RMTI)

Nasdaq: RMTI · Pharmaceutical Preparations · Wixom, MI · filing with the SEC since 1997
Grade4.3
◀ Past 3.4● Present 5.3▶ Future 4.0
1 est.

Filings

395 filings since 2017 beside 227 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
6270334844606747
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest May 8, 2026.Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Nov 18, 2025.SEC letters: 3 in the last 36 months, the newest Oct 17, 2024.
Insider forms 227

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 3, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Nov 2, 2026
Aug 13, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 20, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 29, 2026 8-K items 3.03, 5.03, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Jun 24, 2026
Jun 15, 2026 8-K item 5.07 Shareholder vote · Current report Jun 12, 2026
May 11, 2026 DEFA14A Extra proxy material
May 8, 2026 8-K item 3.01 Listing warning from its exchange · Current report
May 7, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2026 DEF 14A Proxy statement
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 20, 2026 PRE 14A Preliminary proxy statement
Mar 26, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 26, 2026 10-K Annual report Dec 31, 2025
Mar 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 20, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 5, 2026 8-K item 8.01 Other event · Current report Dec 31, 2025
Nov 18, 2025 8-K item 5.02 Officer or director change · Current report Nov 17, 2025
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 12, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Sep 29, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Sep 23, 2025
Aug 14, 2025 SCHEDULE 13G Large holder notice
Aug 14, 2025 S-8 Employee stock plan registration
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Aug 14, 2025 8-K items 2.02, 9.01 Results released · Current report
May 20, 2025 8-K item 5.07 Shareholder vote · Current report
May 15, 2025 SCHEDULE 13G/A Large holder update, amended
May 12, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 12, 2025 10-Q Quarterly report Mar 31, 2025
May 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Apr 14, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 14, 2025 DEF 14A Proxy statement May 20, 2025
Mar 20, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
40 of 395 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton RMTI · research, not advice